News Search

15 Jun 2015 | Other

Actavis plc is now Allergan plc

Actavis plc announced that the company has adopted Allergan plc (NYSE: AGN) as its new global name and will begin trading today under a new symbol — AGN — after ringing The Opening Bell at the New York Stock Exchange.  The company name change follows the acquisition of Allergan in March 2015 and the approval of the name change by Actavis shareholders on June 5.

The combination of Allergan and Actavis created one of the world's top 10 pharmaceutical companies by revenue and a leader in a new industry model – Growth Pharma.

"Today is an exciting day for Allergan and our 30,000 employees around the world who have helped us reach this special moment," said Brent Saunders, CEO and President of Allergan.  "By adopting the Allergan name, we are ensuring that our corporate identity reflects the transformation of our company within the pharmaceutical industry and our position as a dynamic new breed of company – a leader in Growth Pharma.
Today, under one company name and identity, we set out on a new path forward, encouraging our employees across the globe to be bold in how we think and act, to engage and to move quickly to meet the needs of physicians, patients and customers."

Full story on Allergan.com
Media Contacts
Mark Marmur
Global Corporate Media Relations
Tel: +1 (862) 261 7558
Fran DeSena
U.S. Product Media Relations
Tel: +1 (201) 427-8762

Karina Calzadilla
Investor Relations
Tel: +1 862 261 7488